Cabot Corporation (NYSE:CBT) Stock Has Consensus Price Target of $87.80

Key Points

• Analysts maintain a consensus “Hold” rating on Cabot, with four holds, two buys and one sell among seven firms. The average 12-month price target is $87.80, versus the stock’s reported opening price of $72.84.
• Cabot exceeded quarterly expectations, reporting $1.67 in adjusted EPS versus a $1.66 consensus estimate and $982 million in revenue, up 6.4% year over year. Analysts expect approximately $6.35 in EPS for the current year.
• CEO Sean Keohane sold 134,895 shares worth about $11.5 million, while insiders sold roughly $19.6 million of stock over the quarter. Institutional investors remain heavily involved, owning 93.18% of the company.

Cabot Corporation (NYSE:CBT - Get Free Report) has been given an average recommendation of "Hold" by the seven ratings firms that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $87.80.

A number of research firms recently commented on CBT. Wall Street Zen upgraded Cabot from a "hold" rating to a "buy" rating in a report on Sunday, October 11th. JPMorgan Chase & Co. increased their price target on shares of Cabot from $70.00 to $78.00 and gave the stock an "underweight" rating in a research note on Friday, August 7th. Weiss Ratings reissued a "hold (c)" rating on shares of Cabot in a report on Friday, August 21st. UBS Group lowered their price target on shares of Cabot from $92.00 to $86.00 and set a "neutral" rating on the stock in a research report on Monday, October 5th. Finally, Truist Financial set a $100.00 target price on Cabot in a research report on Wednesday, August 5th.

Cabot Price Performance

Shares of NYSE CBT opened at $72.84 on Tuesday. The stock has a market capitalization of $3.76 billion, a price-to-earnings ratio of 20.52, a PEG ratio of 8.69 and a beta of 0.83. Cabot has a 12 month low of $58.33 and a 12 month high of $94.53. The firm's 50 day simple moving average is $78.88 and its 200-day simple moving average is $79.46. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.97.

Cabot (NYSE:CBT - Get Free Report) last announced its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, topping the consensus estimate of $1.66 by $0.01. Cabot had a return on equity of 20.29% and a net margin of 5.23%. The business had revenue of $982.00 million during the quarter, compared to the consensus estimate of $943.16 million. During the same period in the prior year, the company posted $1.90 EPS. The business's quarterly revenue was up 6.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Analysts expect that Cabot will post 6.35 EPS for the current year.

Insider Transactions at Cabot

In other Cabot news, CEO Sean Keohane sold 134,895 shares of the business's stock in a transaction on Friday, August 28th. The shares were sold at an average price of $85.00, for a total value of $11,466,075.00. Following the transaction, the chief executive officer owned 404,134 shares in the company, valued at $34,351,390. The trade was a 25.03% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Over the last quarter, insiders have sold 229,597 shares of company stock worth $19,646,746. Insiders own 3.08% of the company's stock.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the company. Signaturefd LLC raised its position in shares of Cabot by 43.6% during the 3rd quarter. Signaturefd LLC now owns 1,954 shares of the specialty chemicals company's stock worth $150,000 after purchasing an additional 593 shares during the period. Sterling Capital Management LLC raised its position in shares of Cabot by 117.5% during the third quarter. Sterling Capital Management LLC now owns 6,954 shares of the specialty chemicals company's stock worth $535,000 after purchasing an additional 3,757 shares during the period. Inspire Investing LLC lifted its position in shares of Cabot by 10.5% in the 3rd quarter. Inspire Investing LLC now owns 8,251 shares of the specialty chemicals company's stock valued at $635,000 after acquiring an additional 784 shares in the last quarter. Root Financial Partners LLC purchased a new stake in Cabot in the 3rd quarter worth about $27,000. Finally, Nisa Investment Advisors LLC lifted its position in Cabot by 36.7% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,140 shares of the specialty chemicals company's stock worth $165,000 after buying an additional 575 shares in the last quarter. Institutional investors and hedge funds own 93.18% of the company's stock.

About Cabot

Cabot Corporation NYSE: CBT is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company develops and manufactures materials used to improve the performance, durability, conductivity, color and purity of products across a range of industries.

Cabot's products include carbon black used in tires, rubber goods, coatings, plastics and printing inks; specialty carbons and conductive materials for batteries and other applications; and specialty compounds and masterbatches.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.